BridgeBio Oncology Therapeutics BBOT
NASDAQ BBOT
$2.76 +0.08 (+2.99%)
As of: Oct 22, 2026 · 10:14 AM EDT

BridgeBio Oncology Therapeutics (BBOT) Shares Repurchased (2024)

Updated

Analysis

BridgeBio Oncology Therapeutics (BBOT) Shares Repurchased (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,164.71 Bn 1,133.30 Bn 19.71 Bn 1.60 Bn
2 Johnson & Johnson 633.37 Bn 551.90 Bn 17.26 Bn 221.00 Mn
3 AbbVie 503.99 Bn 477.10 Bn 12.70 Bn 9.00 Mn
4 Merck 378.19 Bn 332.57 Bn 12.21 Bn 757.00 Mn
5 Novartis Ag 303.15 Bn 267.14 Bn 11.24 Bn 1.20 Bn
6 Astrazeneca 266.17 Bn 239.85 Bn 12.86 Bn -
7 Amgen 241.38 Bn 196.78 Bn 7.24 Bn -
8 Gilead Sciences 194.07 Bn 168.27 Bn 6.22 Bn 355.00 Mn
9 Pfizer 172.31 Bn 118.96 Bn 10.94 Bn -
10 BridgeBio Oncology Therapeutics 220.95 Mn -1.15 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 578,550.00
API Access

BridgeBio Oncology Therapeutics Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=BBOT&period=max&api_key=YOUR_API_KEY